---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-23-007598"
form_type: "8-K"
ticker: "ODYY"
cik: "0001626644"
company_name: "Odyssey Health, Inc."
filed_at: "2023-11-02T23:59:59+00:00"
generated_at: "2026-06-09T00:28:51.231247+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Odyssey Health extends maturity of officer/director promissory notes to Jan 31, 2024; conversion at $0.12/share

## Summary
- Extended maturity of $25,000 promissory notes from two officers and two directors to January 31, 2024.
- Conversion price remains at $0.12 per share; notes convertible prior to maturity.
- All other terms of the original December 2021 notes unchanged.
- This is the seventh amendment to the notes, previously amended multiple times in 2022 and 2023.

## SEC filing metadata
- accession: 0001683168-23-007598
- form_type: 8-K
- ticker: ODYY
- cik: 0001626644
- company_name: Odyssey Health, Inc.
- filed_at: 2023-11-02T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1626644/000168316823007598/0001683168-23-007598-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1626644/000168316823007598/odyssey_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-23-007598
- JSON: https://secwatch.observer/filing/0001683168-23-007598.json
- Plain text: https://secwatch.observer/filing/0001683168-23-007598.txt

## Key facts
- Debt Financings
  Odyssey Health, Inc. amended loan with two directors and two officers of the Company maturing January 31, 2024.
  - Instrument: loan
  - Counterparty: two directors and two officers of the Company
  - Maturity: January 31, 2024
  - Event: amendment
  source text: On November 1, 2023, Odyssey Health, Inc., formerly known as Odyssey Group International, Inc. (the “Company”), entered into four Promissory Note Amendments (the “Amendments”), to the Promissory Notes entered into December 21, 2021 and December 22, 2021 and as amended April 20, 2022, June 3, 2022, September 30, 2022, December 30, 2022, March 31, 2023 and June 30, 2023, with two directors and two officers of the Company. Pursuant to the Amendments, the parties have agreed to extend the maturity date of the note to January 31, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1626644/000168316823007598/0001683168-23-007598-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.